The AI in life sciences market is experiencing robust expansion due to several important factors. Rising demand for accelerated drug discovery and development is prompting pharmaceutical and biotechnology companies to implement AI technologies that can shorte…
The India cell-based assay market is poised for growth due to increased drug discovery activities, automation in high-throughput screening, and outsourcing to CROs. Opportunities exist in 3D cell culture models, AI integration, stem cell research, oncology, a…

Agreement strengthens Aurigene's discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India, May 13, 2026 /PRNewswire/ -- ERS Genomics Limi…